HROW vs JPM · rev $114.9M vs P/E 14, rev $57.35B
Harrow Health Inc (HROW) versus JPMorgan Chase & Co (JPM) — a side-by-side from cached financials, not a winner call.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Latest reported HROW revenue for 2026-06-30 was $114.9M. Net income was -$44.9M. HROW currently screens at market cap $1.28B.
Latest reported JPM revenue for 2026-06-30 was $57.35B. Net income was $21.16B. Revenue was up 15.1% from 2026-03-31 to 2026-06-30. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
HROW currently screens at market cap $1.28B. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Not investment advice. Open the HROW and JPM stock pages for the full models.
Not investment advice.